Passage Bio Inc. (NASDAQ: PASG)
$0.95
+0.0288 ( +3.13% ) 1.4M
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease.
Market Data
Open
$0.95
Previous close
$0.92
Volume
1.4M
Market cap
$58.63M
Day range
$0.87 - $1.12
52 week range
$0.58 - $1.79
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| def | Proxies and info statements | 4 | Apr 09, 2024 |
| ars | Annual reports | 1 | Apr 09, 2024 |
| 4 | Insider transactions | 1 | Mar 19, 2024 |
| 4 | Insider transactions | 1 | Mar 19, 2024 |
| 4 | Insider transactions | 1 | Mar 19, 2024 |
| 4 | Insider transactions | 1 | Mar 19, 2024 |
| 10-k | Annual reports | 89 | Mar 04, 2024 |
| 8-k | 8K-related | 46 | Mar 04, 2024 |
| 8-k | 8K-related | 14 | Feb 29, 2024 |
| 4 | Insider transactions | 1 | Feb 13, 2024 |